Prot #IRB17-0547/NU UC20L05: A Randomized Phase I Trial to Evaluate Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study)

Project: Research project

Project Details

StatusActive
Effective start/end date1/11/211/11/24

Funding

  • University of Chicago (Prot #IRB17-0547/NU UC20L05)
  • Bristol-Myers Squibb Company (Prot #IRB17-0547/NU UC20L05)